NDPH
MCID: NWD001
MIFTS: 22

New Daily-Persistent Headache (NDPH)

Categories: Rare diseases

Aliases & Classifications for New Daily-Persistent Headache

MalaCards integrated aliases for New Daily-Persistent Headache:

Name: New Daily-Persistent Headache 53
New Daily Persistent Headache 72
Ndph 53

Classifications:



External Ids:

UMLS 72 C2349426

Summaries for New Daily-Persistent Headache

MalaCards based summary : New Daily-Persistent Headache, also known as new daily persistent headache, is related to headache and migraine with or without aura 1, and has symptoms including headache An important gene associated with New Daily-Persistent Headache is TNF (Tumor Necrosis Factor). The drugs Propofol and Naltrexone have been mentioned in the context of this disorder. Affiliated tissues include testes and thyroid.

Wikipedia : 75 New daily persistent headache (NDPH) is a primary headache syndrome which can mimic chronic migraine and... more...

Related Diseases for New Daily-Persistent Headache

Graphical network of the top 20 diseases related to New Daily-Persistent Headache:



Diseases related to New Daily-Persistent Headache

Symptoms & Phenotypes for New Daily-Persistent Headache

UMLS symptoms related to New Daily-Persistent Headache:


headache

Drugs & Therapeutics for New Daily-Persistent Headache

Drugs for New Daily-Persistent Headache (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 20)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Propofol Approved, Investigational, Vet_approved Phase 2 2078-54-8 4943
2
Naltrexone Approved, Investigational, Vet_approved Phase 1, Phase 2 16590-41-3 5360515
3
Ethanol Approved Phase 1, Phase 2 64-17-5 702
4
Acetylcholine Approved, Investigational Phase 2 51-84-3 187
5 Analgesics Phase 2
6 Central Nervous System Depressants Phase 2
7 Hypnotics and Sedatives Phase 2
8 Anesthetics Phase 2
9 Anesthetics, General Phase 2
10 Anesthetics, Intravenous Phase 2
11 Narcotics Phase 1, Phase 2
12 Narcotic Antagonists Phase 1, Phase 2
13 Peripheral Nervous System Agents Phase 2
14 abobotulinumtoxinA Phase 2
15 Neurotransmitter Agents Phase 2
16 Neuromuscular Agents Phase 2
17 Cholinergic Agents Phase 2
18 Acetylcholine Release Inhibitors Phase 2
19 Botulinum Toxins Phase 2
20 Botulinum Toxins, Type A Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 The Effect of Single-dose Propofol Injection on Pain and Quality of Life in Chronic Daily Headache: a Randomized Double-blind Controlled Trial Completed NCT00228267 Phase 2 Propofol
2 Endogenous Modulation and Central Sensitization in New Daily Persistent Headache ( NDPH ) in Children Recruiting NCT03447782 Phase 1, Phase 2 Naltrexone HCl (Bulk) Powder
3 OnabotulinumtoxinA for the Treatment of New Daily Persistent Headache: an Open Label Study Terminated NCT01920945 Phase 2 OnabotulinumtoxinA
4 A Comparison Of Subjects With New Daily Persistent Headache (NDPH) And Subjects With Transformed Migraine (TM) Completed NCT00335803
5 Do Patients With Chronic Daily Headache Have Continuous Headache or Moments of Headache Relief? Completed NCT00880425
6 SunStar Project to Explore the Chronification Process in Headache Through Functional Imaging, Deep Phenotyping, and Analysis of CSF of Blood Products Recruiting NCT03231241

Search NIH Clinical Center for New Daily-Persistent Headache

Genetic Tests for New Daily-Persistent Headache

Anatomical Context for New Daily-Persistent Headache

MalaCards organs/tissues related to New Daily-Persistent Headache:

41
Testes, Thyroid

Publications for New Daily-Persistent Headache

Articles related to New Daily-Persistent Headache:

(show top 50) (show all 175)
# Title Authors PMID Year
1
Emerging evidence of occipital nerve compression in unremitting head and neck pain. 38
31266456 2019
2
New daily persistent headache: a systematic review on an enigmatic disorder. 38
31307396 2019
3
New daily persistent headache (NDPH) triggered by a single Valsalva event: A case series. 38
30301379 2019
4
Multiple cranial nerve blocks for the transitional treatment of chronic headaches. 38
31084198 2019
5
An RCVS Spectrum Disorder? New Daily Persistent Headache Starting as a Single Thunderclap Headache (3 New Cases). 38
30830966 2019
6
New Daily Persistent Headache? Comment on "Pediatric Headache and Sleep Disturbance: A Comparison of Diagnostic Groups". 38
30973198 2019
7
Tracking patients with chronic occipital headache after occipital nerve decompression surgery: A case series. 38
30217120 2019
8
Nonmigraine Headache and Facial Pain. 38
30704679 2019
9
"Klingon headache" - a case report of mimic new daily persistent headache associated to primary essential cutis verticis gyrata. 38
30993299 2019
10
Current perspectives on the development and treatment of chronic daily headache in children and adolescents. 38
30681030 2019
11
New Daily Persistent Headache: a Diagnostic and Therapeutic Odyssey. 38
30888529 2019
12
Resolution of new daily persistent headache by a tumor necrosis factor alpha antagonist, Venlafaxine. 38
31105954 2019
13
New Daily Persistent Headache and OnabotulinumtoxinA Therapy. 38
30499777 2019
14
Differences in Pediatric Headache Prescription Patterns by Diagnosis. 38
29275494 2018
15
Flunarizine in migraine-related headache prevention: results from 200 patients treated in the UK. 38
29512871 2018
16
New daily persistent headache: An evolving entity. 38
29766926 2018
17
Pediatric Headache and Sleep Disturbance: A Comparison of Diagnostic Groups. 38
29044497 2018
18
Treatment of disabling headache with greater occipital nerve injections in a large population of childhood and adolescent patients: a service evaluation. 38
29340791 2018
19
Post-Dengue New Daily Persistent Headache: Comment. 38
29124756 2017
20
Post-Dengue New Daily Persistent Headache. 38
28796302 2017
21
Psychiatric comorbidity in new daily persistent headache: A cross-sectional study. 38
28146324 2017
22
New Daily Persistent Headache: Historical Review and an Interview with Dr. Walter Vanast. 38
28488355 2017
23
Management of children and young people with headache. 38
27998893 2017
24
A Prospective Cohort Study of Outpatient Interdisciplinary Rehabilitation of Chronic Headache Patients. 38
28127753 2017
25
Ketamine Infusions for Treatment Refractory Headache. 38
28025837 2017
26
New Daily Persistent Headache Caused by a Multinodular Goiter and Headaches Associated With Thyroid Disease. 38
28025831 2017
27
Peripheral Nerve Blocks for the Treatment of Headache in Older Adults: A Retrospective Study. 38
27901275 2017
28
Characterising the premonitory stage of migraine in children: a clinic-based study of 100 patients in a specialist headache service. 38
27770403 2016
29
Patterns of Use of Peripheral Nerve Blocks and Trigger Point Injections for Pediatric Headache: Results of a Survey of the American Headache Society Pediatric and Adolescent Section. 38
27731894 2016
30
Aprepitant for the management of nausea with inpatient IV dihydroergotamine. 38
27629088 2016
31
New daily persistent headache: A lack of an association with white matter abnormalities on neuroimaging. 38
26498346 2016
32
Chronic Daily Headache and Medication Overuse Headache in First-Visit Headache Patients in Korea: A Multicenter Clinic-Based Study. 38
27449912 2016
33
New Daily Persistent Headache. 38
27432630 2016
34
Update on New Daily Persistent Headache. 38
27080086 2016
35
New Daily Persistent Headache Is Most Likely to Begin at the Start of School. 38
26733504 2016
36
A Survey of Headache Medicine Physicians on the Likeability of Headaches and Their Personal Headache History. 38
26926707 2016
37
Resolution of New Daily Persistent Headache After Osteopathic Manipulative Treatment. 38
26927912 2016
38
Patients with tension-type headaches feel stigmatized. 38
27011641 2016
39
Triggering Events and New Daily Persistent Headache: Age and Gender Differences and Insights on Pathogenesis-A Clinic-Based Study. 38
26474179 2016
40
Update of Inpatient Treatment for Refractory Chronic Daily Headache. 38
26707496 2016
41
Spontaneous Intracranial Hypotension Treated with a Targeted CT-Guided Epidural Blood Patch. 38
26981128 2016
42
P009. A case of new daily persistent headache treated with botulinum toxin type A. 38
28132269 2015
43
Connective tissue, Ehlers-Danlos syndrome(s), and head and cervical pain. 38
25655119 2015
44
New daily persistent headache with isolated sphenoiditis in children. 38
25774200 2015
45
[Changes introduced into the recent International Classification of Headache Disorders: ICHD-III beta classification]. 38
25583591 2015
46
Mirtazapine for new daily persistent headache-associated chronic nausea. 38
25262618 2015
47
Endoscopic forehead surgery for migraine therapy Personal technique. 38
25711848 2014
48
New daily persistent headache: an update. 38
24820732 2014
49
Validation of a guideline-based decision support system for the diagnosis of primary headache disorders based on ICHD-3 beta. 38
24934331 2014
50
Outcomes of greater occipital nerve injections in pediatric patients with chronic primary headache disorders. 38
24268688 2014

Variations for New Daily-Persistent Headache

Expression for New Daily-Persistent Headache

Search GEO for disease gene expression data for New Daily-Persistent Headache.

Pathways for New Daily-Persistent Headache

GO Terms for New Daily-Persistent Headache

Sources for New Daily-Persistent Headache

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....